Skip Nav Destination
.jpg?versionId=5954)
President's Column
With an Eye on Quality, ASH to Launch New Journals
Aug 17, 2023
In January, ASH plans to launch two peer-reviewed journals: Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis (VTH). Learn what readers can expect.
Mentoring Makes the Difference
Four mentor-mentee pairs share their experiences as part of a program under ASH’s Minority Recruitment Initiative, which turns 20 this year.
MEN1 Mutations Induce Acquired Resistance to the Menin Inhibitor Revumenib
Contributing Editor Christine McMahon, MD, shares her insights on a study that assesses the mechanisms underlying acquired resistance to revumenib.
Rilzabrutinib for Persistent ITP: New Kid on the Block?
Researchers are studying the efficacy of rilzabrutinib for the treatment of primary, persistent immune thrombocytopenia.
